• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sun Pharma Advanced Research Company Ltd Miscellaneous

  • Sun Pharma
  • BSE Code : 27675.0
  • ISIN : INE232I01014
149.84 -1 (-0.46%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    148.51

  • Today’s High

    153.99

  • Open

    150.00

  • Perv Close

    150.54

  • 52W Low

    109.30

  • 52W High

    241.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    4,862.63

  • Div & Yield %

    0.00

  • Book Value(₹)

    -6.80

  • Debt-Equity Ratio

    -0.46

  • AGM Date

    01-Aug-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.12

  • Mar.Cap (₹Cr.)

    4,862.63

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    32.45

  • BV (₹)

    -6.80

  • Sales( ₹ in Cr.)

    71.77

  • NP (in Cr.)

    -345.25

  • NP Var(%)

    11.0

  • Div%

    0.0

  • CPS (₹)

    -10.30

  • EPS (₹)

    -10.60

  • Traded Value (₹ in Lakhs)

    4,849.98

  • 52 Week High

    241.00

  • 52 Week Low

    109.30

  • Price BSE

    149.0

  • Price NSE

    150.00

  • Market Capital( in Cr.)

    4,849.98

  • P/C Ratio

    -14.50

  • P/E Ratio

    -14.00

  • Price Vs.BV

    -10.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 71.77 75.55 238.78 137.25 252.96 76.81
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 71.77 75.55 238.78 137.25 252.96 76.81
Other Income 1.79 29.47 10.88 6.84 5.41 9.76
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 73.56 105.02 249.66 144.09 258.37 86.57
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 18.27 18.18 23.93
Power and Fuel Cost 6.33 6.14 5.75 4.62 4.60 5.14
Employee Cost 108.96 118.53 107.00 98.31 91.59 93.09
Other Manufacturing Expenses 48.01 55.37 45.51 17.06 17.93 10.59
Selling and Administration Expenses 230.99 292.27 289.71 183.33 252.17 247.28
Miscellaneous Expenses 4.75 7.03 4.87 2.41 3.48 6.81
Employee Benefit Expenses 108.96 118.53 107.00 98.31 91.59 93.09
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 399.04 479.34 452.84 324.00 387.94 386.83
Operating Profit -325.48 -374.32 -203.18 -179.90 -129.57 -300.25
Interest 8.91 1.66 7.63 13.33 10.65 2.67
Gross Profit -334.39 -375.98 -210.81 -193.23 -140.22 -302.92
Depreciation 10.83 12.13 11.77 10.16 10.92 9.48
Profit Before Tax -345.22 -388.11 -222.58 -203.39 -151.14 -312.40
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -345.22 -388.11 -222.58 -203.40 -151.14 -312.40
Extraordinary Items 0.03 0.58 -0.11 4.89 0.26 6.27
Adjusted Net Profit -345.25 -388.69 -222.47 -208.29 -151.40 -318.67
Adjustment below Net Profit -0.26 0.19 1.35 1.70 1.53 -2.47
P & L Balance brought forward -1,979.73 -1,591.81 -1,370.58 -1,168.88 -1,019.27 -704.40
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -2,325.21 -1,979.73 -1,591.81 -1,370.58 -1,168.88 -1,019.27
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -10.64 -11.96 -6.86 -7.48 -5.77 -11.92
Earnings Per Share(Adj)-Unit Curr -10.64 -11.96 -6.86 -7.48 -5.77 -11.92
Book Value -6.80 3.85 15.80 -7.47 -6.42 -0.71
Book Value(Adj)-Unit Curr -6.80 3.85 15.80 -7.47 -6.42 -0.71

Shareholding Pattern

  • Promoter Group

    65.67%

  • Public Share Holding

    34.33%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 147,674,210 45.51 147,673,010 8
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 65,440,885 20.17 65,440,885 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 213,115,095 65.67 213,113,895 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 668 0.00 668 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 650 0.00 566 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 4,783,225 1.47 4,783,225 25
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 1,200 0.00 0 1
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 3,041,806 0.94 3,041,706 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 107,029 0.03 107,029 7
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 7,934,578 2.45 7,933,194 46
2] Non Institution
Bodies Corporate 23,538,865 7.25 23,527,131 623
Clearing Members 5,569 0.00 5,569 7
Directors of their Relatives 724,310 0.22 724,310 11
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 9,600 0.00 9,600 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,250,312 0.69 2,240,608 1,913
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,622,278 0.81 2,622,278 3,026
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 13,945,112 4.30 13,945,112 18
Individuals holding nominal share capital up to Rs. 1 lakh 48,207,272 14.85 47,681,380 134,991
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 7,068 0.00 7,068 6
Others 11,352,389 3.50 11,352,389 4
Sub Total 103,471,915 31.88 102,924,369 140,664
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 324,521,588 100.00 323,971,458 140,724

Company Background

Sun Pharma Advanced Research Company LtdMiscellaneous

  • Sun Pharma Advanced Research Company Ltd
  • BSE Code : 27675.0
  • ISIN : INE232I01014

  • Incorporation Year

    2006

  • Registered Office

    Sun Pharma Advanced Res Centre
    Akota Road Akota, Vadodara,
    Gujarat-390020

  • Telephone

    91-265-2330815/2339257

  • FAX

    91-265-2354897

  • Chairman

    Dilip S Shanghvi

  • Managing Director

  • Company Secretary

    Kajal Damania.

  • Auditor

    S R B C & Co LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Sun Pharma Advanced Research Company Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SPARC 149.45 73.56 71.77 -14.05 0.00
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10